Rosenblum Silverman Sutton S F Inc Pfizer Inc Transaction History

Rosenblum Silverman Sutton S F Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$43.76 - $53.42 $3.27 Million - $3.99 Million	-74,756 Reduced 92.81%	5,795 $254,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $3.23 Million - $3.94 Million	73,831 Added 1098.68%	80,551 $254,000
Q3 2020 Nov 09, 2020	BUY	$31.75 - $37.25 $213,360 - $250,320	6,720 New	6,720 $247,000
Q4 2019 Jan 24, 2020	SELL	$32.92 - $37.36 $194,063 - $220,237	-5,895 Closed	0 $0
Q3 2019 Nov 01, 2019	SELL	$32.49 - $42.13 $5,685 - $7,372	-175 Reduced 2.88%	5,895 $212,000
Q2 2019 Jul 31, 2019	BUY	$36.98 - $41.52 $224,468 - $252,026	6,070 New	6,070 $263,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Rosenblum Silverman Sutton S F Inc , based on Form 13F filings with the SEC.

Stay updated on Rosenblum Silverman Sutton S F Inc with notifications on news.